NCT04744662 - ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 8, 2021

Primary Completion Date

February 29, 2024

Study Completion Date

February 29, 2024

Conditions

Geographic Atrophy

Interventions

DRUG

ONL1204 Ophthalmic solution

Liquid formulation administered by intravitreal (IVT) injection

PROCEDURE

sham injection

sham injection is done by touching the eye surface with a syringe without a needle

Trial Locations (8)

Eye Institute Limited, Remuera

Chatswood Retina, Chatswood

Retina and Eye Consultants Hurtsville, Hurstville

Sunshine Eye Surgeons, St Albans

Retinology Institute, Glen Iris

Queensland Eye Institute, Melbourne

Southern Eye Specialists, Christchurch

Center for Eye Rearch Australia, Melbourne